Research & Development

Turn Biotechnologies to move onto the next stage of cell rejuvenation program with the help of pharma organizations.

Turn Biotechnologies has been able to successfully secure fundraising from global pharmaceutical organizations through an oversubscribed funding round. These include HanAll Biopharma,...

Covid-19 Oral Treatment to be developed jointly by Sen-Jam Pharmaceuticals and KVK Tech

According to the partnership, KVK Tech will formulate the oral COVID medication and also offer CMC data. KVK tech...

Access to Lumykras increased in the U.K through collaboration between Amgen and NHS

The NHS has reached a landmark agreement with Amgen Pharmaceuticals to expand the distribution of Lumykras, a treatment option for lung cancer....

Santhera advances gene therapy for LAMA2 MD through deal with Seal Therapeutics

Santhera Pharmaceuticals and Seal Therapeutics' partnership aims to develop gene therapy for the disease known as LAMA2-deficient congenital muscular dystrophy, or LAMA2...

Algernon Pharmaceuticals Starts both Repirinast Production and CKD Research Program

Vancouver-based Algernon Pharmaceuticals has granted a contract to Chinese Zhejiang Ausun Pharmaceutical for mass production of Repirinast along the lines of Current...

Vallon Pharmaceutical successful in getting U.S. Patent for COVID-19 brain fog treatment drug ADAIR

Covid-19 brain fog treatment drug, ADAIR, has been issued a patent by the US. Patent and Trademark Office. The drug has been...

Mekonos closes $25M funding round for cell therapy platform

Mekonos closes funding of $25M in a series a round as it develops the future of cell therapies on a chip. The...

Superbugs Could Be the Next Pandemic: We Need a Global, Comprehensive Plan to Address Them Now!

COVID-19 is clearly a generation-defining public health crisis; one which could have a lasting impact on many facets of our lives for many years to come.

Latest news

Zealand Pharma and Iktos collaborate to develop AI Technology for Peptide drug design

Specialists in artificial intelligence for new drug design, Iktos announced a research partnership with Zealand Pharma to...
- Advertisement -

UK’s NICE makes recommendation for Imlifidase by Hansa Biopharmaceutical

With the National Institute for Health and Care Excellence’s (NICE) recommendation for the use of imlifdase, over...

Heart failure drug by Cytokinetics delayed – FDA wants more time to review

The Food and Drug Administration requires more time to study Cytokinetics’ omecamtiv mecarbil following analysis of some...

Must read

Surrounded by controversy, FDA approves Biogen’s Alzheimer’s drug Aduhelm

In the middle of the debate about the Alzheimer’s drug approval, the United States FDA has authorized Aduhelm

Amgen’s KRAS drug gets early FDA approval for lung cancer with specific mutation

On Friday, the United States FDA (Food and Drug Administration) has authorized a medication of Amgen Biopharmaceutical in patients with NSCLC

You might also likeRELATED
Recommended to you

Janssen files for Covid19 vaccine approval in Japan

Janssen pharmaceuticals K.K., a department of Johnson& Johnson pharmaceuticals, has announced on Monday that it has applied to the Health Ministry of Japan to approve its Covid-19 vaccine.

Purdue Pharma’s exeuctives to get $7M bonus authorized by federal judge

A U.S. federal judge upon approving bonuses...

$3.3B takeover agreed between buyer GSK and Affinivax

GlaxoSmithKline (GSK) reached a deal to purchase...